Dr. Paul Burton, Moderna's main aesculapian officer, says helium is "absolutely confident" that information connected the company's vaccine for young children volition beryllium acceptable for the FDA to reappraisal astatine its June meeting.
Dr. Paul Burton, Moderna's main aesculapian officer, says helium is "absolutely confident" that information connected the company's vaccine for young children volition beryllium acceptable for the FDA to reappraisal astatine its June meeting.